4 resultados
FIELD OF THE INVENTION
A method and system for treating and preventing cancer employing CRISPR-Cas technology to modify an individual's microbiome, and in particular to a method and system designed to produce tomatidine and/or rapamycin in an individual's microbiome in order to combat cancer.
FIELD OF THE INVENTION
A method and system for treating and preventing cancer employing CRISPR-Cas technology to modify an individual's microbiome, and in particular to a method and system designed to produce tomatidine and/or rapamycin in an individual's microbiome in order to combat cancer.
FIELD OF THE INVENTION
A method and system for treating cancer cachexia employing CRISPR-Cas technology to modify an individual's microbiome, and in particular to a method and system designed to produce tomatidine in an individual's microbiome in order to combat cancer cachexia.
BACKGROUND OF THE
FIELD OF THE INVENTION
A method and system for treating cancer cachexia employing CRISPR-Cas technology to modify an individual's microbiome, and in particular to a method and system designed to produce one of tomatidine, statins, and/or p53 in an individual's microbiome in order to combat cancer